Skip to main content

News

Filter by:
  • Tinne Van der Straeten, ministre de l'énergie, souligne l'importance de ce projet et l'expertise des deux partenaires. « La Belgique veut rester un leader mondial dans la production d'isotopes médicaux. C'est pourquoi, dans le cadre du plan de relance européen, nous avons apporté notre soutien au SCK CEN pour leur permettre d'innover dans le domaine des radiopharmaceutiques thérapeutiques. SCK CEN et IBA combinent leurs grandes expertises dans ce partenariat de R&D afin de collaborer sur des isotopes qui pe
    15 September '21

    IBA and SCK CEN join forces to enable production of Actinium-225

    Louvain-La-Neuve, Belgium, 15 September 2021 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, and SCK CEN (Belgian Nuclear Research Center) today announce a strategic R&D partnership to enable the production of Actinium-225 (225Ac), a novel radioisotope which has significant potential in the treatment of cancer.

  • SCK CEN - Smartphones als ‘toevallige dosimeters’ (2021)
    14 July '21

    Smartphones are ‘casual dosimeters’

    Smartphones can serve as ‘casual dosimeters’ in radiological incidents. By reading the resistors inside them, researchers can accurately determine the individual dose of radiation sustained afterwards. This was demonstrated in a large-scale experiment by SCK CEN. “This is essential to ensure that, in case of high doses due to an accidental situation, medical aid is provided immediately,” emphasises Olivier Van Hoey, dosimetry expert at SCK CEN.

  • Roger-Van-Geen
    08 July '21

    Thomas Cocolios receives the “Roger Van Geen” chair

    The Research Foundation – Flanders (FWO) and the Fund for Scientific Research (F.R.S.–FNRS) awarded the “Roger Van Geen” chair to Thomas Cocolios, professor at KU Leuven. This biennial prize is an initiative of SCK CEN. This year, it rewards the career of T.E. Cocolios in the field of nuclear physics and nuclear medicine.